Müller-Lisse G U, Kretschmar U L, Jäger L, Dreher A, Grevers G, Reiser M
Institut für Radiologische Diagnostik, Klinikum Grosshadern, Ludwig-Maximilians-Universität München.
Radiologe. 1996 Mar;36(3):199-206. doi: 10.1007/s001170050061.
Evaluation of frequency-selective fat saturation (FS) and short-tau inversion recovery (STIR) fat suppression (FU) in MRI of patients with malignant head and neck tumors.
Forty-five patients with biopsy-proven carcinomas of the extracranial head and neck were examined with MRI at 1.0 T. A T2-weighted TSE sequence with and without STIR-FU and a T1-weighted SE sequence with and without FS were compared in axial slices.
STIR-FU was successful in all and FS in 85-88% of the head examinations (nasopharynx, sinuses, oropharynx, and oral cavity) and 33-46% of the neck examinations (hypopharynx and larynx). When visualization and delineation of tumors were ranked on a four-point scale (0-3), respective mean values for images with/without FU or FS were 2.6/1.9 for T2-TSE in all examinations, 2.2/1.7 (nasopharynx and sinuses) and 1.3/1.4-1.6 (oropharynx, oral cavity, hypopharynx, and larynx) for T1-SE without contrast media administration (CM) and 2.3/2.1 (nasopharynx and sinuses) and 2.4-2.5/1.9-2.0 (oropharynx, oral cavity, hypopharynx, and larynx) with CM.
STIR-T2-TSE was a technically reliable pathfinder for localization and extension of both tumors and lymph nodes. FS-T1-SE was technically unreliable in examinations of the hypopharynx and larynx. With CM, FS-T1-SE was most useful for MRI of carcinomas of the oral cavity and oropharynx. In the nasopharynx and sinuses, T1-SE with CM and FS-T1-SE with or without CM were equal for tumor visualization and delineation.
评估频率选择性脂肪饱和(FS)和短反转时间反转恢复(STIR)脂肪抑制(FU)在头颈部恶性肿瘤患者MRI检查中的应用。
45例经活检证实为颅外头颈部癌的患者接受了1.0 T的MRI检查。在轴位切片上比较了有和没有STIR-FU的T2加权快速自旋回波(TSE)序列以及有和没有FS的T1加权自旋回波(SE)序列。
在所有头部检查(鼻咽、鼻窦、口咽和口腔)中,STIR-FU均成功,FS成功率为85% - 88%;在所有颈部检查(下咽和喉)中,FS成功率为33% - 46%。当根据四点量表(0 - 3)对肿瘤的可视化和轮廓清晰度进行评分时,在所有检查中,有/无FU或FS的T2-TSE图像的各自平均值分别为2.6/1.9;在未注射造影剂(CM)的情况下,T1-SE的平均值分别为2.2/1.7(鼻咽和鼻窦)和1.3/1.4 - 1.6(口咽、口腔、下咽和喉);在注射CM的情况下,T1-SE的平均值分别为2.3/2.1(鼻咽和鼻窦)和2.4 - 2.5/1.9 - 2.0(口咽、口腔、下咽和喉)。
STIR-T2-TSE在肿瘤和淋巴结的定位及范围显示方面是一种技术可靠的引导序列。FS-T1-SE在下咽和喉部检查中技术上不可靠。注射CM后,FS-T1-SE对口腔和口咽癌的MRI检查最有用。在鼻咽和鼻窦中,注射CM的T1-SE与有或无CM的FS-T1-SE在肿瘤可视化和轮廓清晰度方面效果相当。